10-Q: One World Products Inc. Reports Q1 2024 Results Amidst Restructuring
Quarterly Report
One World Products Inc. reported its Q1 2024 financial results, showing a net loss and ongoing restructuring efforts.
Summary
- One World Products Inc. reported a net loss of $1.7 million for the first quarter of 2024, compared to a net loss of $515,938 for the same period in 2023.
- The company's revenue decreased significantly to $282 in Q1 2024 from $2,101 in Q1 2023, primarily due to a shift from seed sales to CBD product sales.
- Operating expenses increased to $777,518 in Q1 2024 from $459,002 in Q1 2023, driven by higher professional fees and stock-based compensation.
- The company deconsolidated its foreign subsidiaries, resulting in a loss of $97,672.
- The company is undergoing reorganization proceedings in Colombia, similar to Chapter 11 bankruptcy in the US.
- As of March 31, 2024, the company had a cash balance of $40,648, negative working capital of $1,871,931, and an accumulated deficit of $28,630,708.
- The company issued 10,971,000 shares of common stock to related parties in exchange for debt modifications, resulting in a loss on early extinguishment of debt of $724,086.
- The company issued 6,500,000 shares of common stock to officers and directors for services provided, valued at $429,000.
Sentiment
Score: 3
Explanation: The document indicates significant financial challenges, including a substantial net loss, declining revenue, and a going concern warning. While there are some positive aspects, such as improved gross profit margin, the overall sentiment is negative due to the company's financial instability and ongoing restructuring.
Positives
- The company's gross profit margin improved to 83% in Q1 2024 from 54% in Q1 2023.
- The company has taken steps to reduce general and administrative expenses, which decreased by 43% compared to the same period last year.
- The company has secured additional debt financing of $332,000 during the quarter.
Negatives
- The company experienced a significant increase in net loss, reaching $1.7 million in Q1 2024.
- Revenue decreased substantially by 87% compared to the same period last year.
- Operating expenses increased by 70% due to higher professional fees and stock-based compensation.
- The company recorded a loss of $724,086 due to the early extinguishment of debt.
- The company has deconsolidated its foreign subsidiaries, resulting in a loss of $97,672.
- The company has a negative working capital of $1,871,931 and an accumulated deficit of $28,630,708.
- The company's cash balance is very low at $40,648.
Risks
- The company's ability to continue as a going concern is in doubt due to its low cash balance, negative working capital, and accumulated deficit.
- The company is undergoing reorganization proceedings in Colombia, which could impact its operations and financial stability.
- The company's revenue is highly dependent on the success of its new CBD product line.
- The company's reliance on debt financing and stock issuances to related parties could dilute shareholder value.
- The company faces potential liabilities from ongoing legal proceedings in Colombia.
Future Outlook
The company expects to explore potential business opportunities, including strategic partnerships, and aims to restore its cannabis operations after emerging from the Reorganization Proceedings. The company also plans to sell CBD flower and distillate oil, and develop new products including CBD-infused coffee, teas, and wellness products.
Management Comments
- Management intends to satisfy OWP SAS's continuing financial obligations through negotiation and/or settlement with creditors and the Colombian governmental authorities.
- Management would seek additional financing and would attempt to conserve cash by further reducing expenses if sales do not materialize at the expected rates.
Industry Context
The company operates in the cannabis and hemp industry, which is subject to evolving regulations and market conditions. The company's focus on both medical and industrial uses of cannabis and hemp aligns with broader industry trends. The company's strategic partnerships with Smokiez Edibles and Stephen Marley's Kx Family Care are indicative of the industry's move towards brand collaborations and product diversification.
Comparison to Industry Standards
- The company's significant revenue decline and net loss are concerning when compared to industry peers that are experiencing growth in the cannabis market.
- The company's high operating expenses, particularly professional fees, are not in line with industry benchmarks for companies of similar size and stage.
- The company's negative working capital and low cash balance are significantly below industry standards for companies seeking to scale operations.
- The company's reliance on debt financing and stock issuances to related parties is not a common practice among well-established cannabis companies.
- The company's ongoing reorganization proceedings in Colombia are a significant deviation from the norm in the industry, indicating severe financial distress.
Legal Proceedings
- OWP SAS is involved in 23 separate lawsuits for various civil and labor disputes in Colombia.
- A complaint was filed in the State of Nevada against One World Products, Inc. by a former employee of OWP SAS.
Related Party Transactions
- The company issued shares of common stock to officers and directors in consideration for extending the maturity dates and terms of previously received debt financing.
- The company issued shares of common stock to officers and directors for services provided.
- The company received advances from related parties through unsecured promissory notes.
Stakeholder Impact
- Shareholders face significant risk due to the company's financial instability and potential dilution from stock issuances.
- Employees may be impacted by the company's restructuring efforts and cost-cutting measures.
- Customers may experience disruptions in product availability due to the company's operational challenges.
- Suppliers and creditors face uncertainty regarding payment of outstanding obligations.
- The company's ability to continue as a going concern is in doubt, which could impact all stakeholders.
Next Steps
- The company will continue to work through the Reorganization Proceedings in Colombia.
- The company will explore potential business opportunities and strategic partnerships.
- The company will attempt to restore its cannabis operations.
- The company will focus on selling CBD flower and distillate oil.
- The company will develop new products including CBD-infused coffee, teas, and wellness products.
Key Dates
| Date | Description |
|---|---|
| 2019-02-21 | The company entered into a merger agreement with OWP Ventures, Inc. |
| 2020-02-12 | The company's stockholders approved the 2019 Stock Incentive Plan. |
| 2022-09-01 | The company entered into a Purchase Agreement with Tysadco Partners, LLC. |
| 2023-06-23 | The company completed the sale of a Promissory Note to AJB Capital Investments LLC. |
| 2023-08-22 | The company entered into an advisor agreement with an individual. |
| 2023-12-22 | OWP SAS filed for protection under Colombian Law 1116 of 2006. |
| 2024-03-04 | The company completed the sale of a promissory note to the Sanguine Group, LLC. |
| 2024-03-15 | The company issued shares of common stock to officers and directors for debt modifications and services. |
| 2024-03-19 | The company received an advance of $50,000 from Joerg Sommer. |
| 2024-04-19 | The company completed the sale of promissory notes to SDT Equities LLC and AJB Capital Investments LLC. |
| 2024-05-10 | The company issued 1,250,000 shares of common stock in consideration of consulting services. |
| 2024-06-10 | The number of shares of the company's common stock outstanding was 104,329,919. |
Keywords
cannabis, CBD, hemp, restructuring, reorganization, debt, equity, financial results, net loss, operating expenses, revenue, stock-based compensation, going concern
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.